LCM
SOPH icon

Legato Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Legato Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
223,230
+6,889
+3% +$35K 0.11% 283
2026
Q1 		$1.07M Buy
+216,341
New +$1.05M 0.1% 272
2024
Q3 		– Sell
-104,083
Closed -$477K – 620
2024
Q2 		$477K Hold
104,083
– – 0.06% 451
2024
Q1 		$513K Buy
104,083
+54,184
+109% +$262K 0.06% 432
2023
Q4 		$235K Buy
+49,899
New +$187K 0.03% 514

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Legato Capital Management's SOPH Position: Q2 2026 in Review

Legato Capital Management increased its SOPHiA GENETICS (SOPH) stake by 3.2% in Q2 2026, buying an estimated $35K and bringing the position to 223,230 shares worth $1.29M. The position accounts for 0.11% of the portfolio, ranked #283.

Legato Capital Management first reported a position in SOPH in Q4 2023 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Legato Capital Management held 223,230 shares of SOPHiA GENETICS worth $1.29M as of Q2 2026.
  • Legato Capital Management bought 6,889 SOPHiA GENETICS shares in Q2 2026, an estimated $35K.
  • SOPHiA GENETICS made up 0.11% of Legato Capital Management's portfolio in Q2 2026, its #283 holding.
  • Legato Capital Management first reported a position in SOPHiA GENETICS in Q4 2023 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.